Hepalatide

· Shanghai HEP Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Hepalatide, covering 2024-04-24 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D [Phase 3]